APA

Khanim F., Davies N., Veliça P., Hayden R., Ride J., Pararasa C., Chong M. G., Gunther U., Veerapen N., Winn P., Farmer R., Trivier E., Rigoreau L., Drayson M. & Bunce C. (20140715). Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. : British journal of cancer.

Chicago

Khanim F, Davies N, Veliça P, Hayden R, Ride J, Pararasa C, Chong M G, Gunther U, Veerapen N, Winn P, Farmer R, Trivier E, Rigoreau L, Drayson M and Bunce C. 20140715. Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. : British journal of cancer.

Harvard

Khanim F., Davies N., Veliça P., Hayden R., Ride J., Pararasa C., Chong M. G., Gunther U., Veerapen N., Winn P., Farmer R., Trivier E., Rigoreau L., Drayson M. and Bunce C. (20140715). Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. : British journal of cancer.

MLA

Khanim F, Davies N, Veliça P, Hayden R, Ride J, Pararasa C, Chong M G, Gunther U, Veerapen N, Winn P, Farmer R, Trivier E, Rigoreau L, Drayson M and Bunce C. Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. : British journal of cancer. 20140715.